Ludwig Institute for Cancer Research - Cancer Immunotherapy Branch Hubs
The Ludwig Institute for Cancer Research has a branch called Cancer Immunotherapy that focuses on developing cancer vaccines and advancing cancer immunotherapy. They have a team of scientists and clinicians who conduct research to understand the immune system's response to cancer and create new vaccine strategies. They collaborate with others and conduct clinical trials to translate their findings into better immunotherapy options for cancer patients.
Headquarters:
Lausanne
Estimated Revenue:
more than US$2.5 billion